Healthtech Investors & VC Firms in Asia-Pacific

838 firms in this list, with a median first check of $600K. 163 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Stonebridge Ventures 3 people	Seoul	KR	Seed–Late Stage	$743K – $33M	+ Add to CRM
Trans-Pacific Technology Fund 8 people	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
Volcanics Venture 8 people	Shanghai	CN	Seed–Series B	—	+ Add to CRM
BIRAC 1 person	New Delhi	IN	Pre-Seed–Series A	—	+ Add to CRM
Lanchi Ventures 1 person · Follows rounds	Singapore	SG	Pre-Seed–Series A	—	+ Add to CRM
HCF Catalyst	Sydney	AU	Seed–Series A	—	+ Add to CRM
Remarkable Australia+ Accelerator Follows rounds	Australia	AU	Pre-Seed–Seed	—	+ Add to CRM
Gaorong Capital 5 people	Beijing	CN	Seed–Series B	—	+ Add to CRM
NDN2 vision fund 2 people · Follows rounds	Hong Kong	HK	Pre-Seed–Late Stage	—	+ Add to CRM
Fosun International 1 person	Shanghai	CN	Series B	—	+ Add to CRM
TriWise Capital 1 person · Leads rounds	Shenzhen	CN	Pre-Seed–Late Stage	—	+ Add to CRM
YFY Biotech Management Company 1 person	Taipei	TW	Seed–Series B	—	+ Add to CRM
Remarkable	—	AU	Pre-Seed–Seed	—	+ Add to CRM
Hokkaido Venture Capital, Inc. 1 person	Sapporo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
WERU Investment Co. Ltd.	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
ABICO Asia Capital Corporation 1 person	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
CCV Capital 1 person · Follows rounds	Beijing	CN	Seed–Series B	—	+ Add to CRM
Haibang Capital 1 person	Hangzhou	CN	Pre-Seed–Late Stage	—	+ Add to CRM
BioTrack Capital 6 people	Grand Cayman	CN	Seed–Late Stage	—	+ Add to CRM
Fosun Pharma	Shanghai	CN	—	—	+ Add to CRM
IMM Investment	Kangnam	KR	Pre-Seed–Growth	$3M – $54M	+ Add to CRM
Dalton Venture	Shanghai	CN	Seed–Series B	—	+ Add to CRM
Mankind Pharma	New Delhi	IN	Series A	—	+ Add to CRM
Symphony International Holdings 3 people	—	HK	Growth–Late Stage	$15M – $100M	+ Add to CRM